← Back
Data updated: Jun 28, 2026
ORCHID PHARMA
Pharma Pharmaceuticals
ORCHID PHARMA is a pharmaceutical company with 1 FDA-approved products.
2024
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
FDA Novel Drug Designations
(2024) 1 Novel 1 Priority Review 1 Fast Track
See 1 novel approval →
ORCHID PHARMA's Key Drugs
ORCHID PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
ORCHID PHARMA's Recent FDA Approvals
New NDA/BLA approvals for ORCHID PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
ORCHID PHARMA's Therapeutic Areas
Disease areas where ORCHID PHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ORCHID PHARMA Pipeline Snapshot
Active clinical trials for ORCHID PHARMA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2024-02-22
- Latest
- 2024-02-22
- Applications
- 1